SCHEMBL20201215

SCHEMBL20201215

Cc1nccnc1C(=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.53
KMT2A Q03164 2/20 0.53
SLC6A2 P23975 1/20 0.53
SLC6A3 Q01959 1/20 0.53
POLB P06746 1/20 0.51
L3MBTL1 Q9Y468 5/20 0.51
TSHR P16473 3/20 0.51
RAB9A P51151 2/20 0.51
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
ALDH1A1 P00352 7/20 0.50
LMNA P02545 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.49
MAPT P10636 4/20 0.48
KDM4E B2RXH2 2/20 0.48
MAOB P27338 2/20 0.48
ADORA2A P29274 2/20 0.48
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20201222 0.83 POLB (0.57) TDP1KMT2ASLC6A2SLC6A3POLB
SCHEMBL21572853 0.82 TDP1 (0.58) TDP1KMT2ASLC6A2SLC6A3POLB
SCHEMBL11274542 0.81 MAPT (0.58) TDP1KMT2ASLC6A2SLC6A3POLB
SCHEMBL20201208 0.81 TDP1 (0.49) TDP1KMT2ASLC6A2SLC6A3POLB
SCHEMBL20201206 0.81 TDP1 (0.49) TDP1KMT2ASLC6A2SLC6A3POLB
SCHEMBL24090784 0.81 POLB (0.55) TDP1KMT2ASLC6A2SLC6A3POLB
SCHEMBL20880260 0.81 POLB (0.51) TDP1KMT2ASLC6A2SLC6A3POLB
SCHEMBL6266108 0.80 POLB (0.69) TDP1KMT2ASLC6A2SLC6A3POLB
SCHEMBL19928470 0.79 TDP1 (0.54) TDP1KMT2ASLC6A2SLC6A3POLB
SCHEMBL25541337 0.79 RAB9A (0.50) TDP1KMT2ASLC6A2SLC6A3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230355590-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL CORPORATION (JP) 2023-11-09 US disclosed
US-20230355590-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL CORPORATION (JP) 2023-11-09 US disclosed
US-20230167067-A1 PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES UNIV NORTH CAROLINA CHAPEL HILL (US) 2023-06-01 US disclosed
US-10874645-B2 Isoxazoline-substituted benzamide compound and pesticide NISSAN CHEMICAL CORPORATION (JP) 2020-12-29 US disclosed
US-20200155511-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL CORPORATION (JP) 2020-05-21 US disclosed
US-20180148414-A1 PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230355590-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE HDAC7, ACHE, BRDT TDP1 3193/4885KMT2A 342/4885SLC6A2 633/4885
US-10874645-B2 Isoxazoline-substituted benzamide compound and pesticide C3AR1, C5, C9 TDP1 4037/4885KMT2A 2752/4885SLC6A2 1623/4885
US-20180148414-A1 PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES PPOX, AOC2, AOC3 TDP1 2574/4885KMT2A 1406/4885SLC6A2 459/4885
US-20200155511-A1 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE C3AR1, C5, C9 TDP1 4037/4885KMT2A 2752/4885SLC6A2 1623/4885
US-20230167067-A1 PHOTOREDOX-CATALYZED DIRECT C-H FUNCTIONALIZATION OF ARENES PPOX, AOC2, AOC3 TDP1 2574/4885KMT2A 1406/4885SLC6A2 459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.